Show simple item record

dc.contributor.advisorChinmay Trivedi
dc.contributor.authorLewandowski, Sara L.
dc.date2022-08-11T08:08:46.000
dc.date.accessioned2022-08-23T16:07:30Z
dc.date.available2022-08-23T16:07:30Z
dc.date.issued2016-12-21
dc.date.submitted2017-01-30
dc.identifier.doi10.13028/M26P4D
dc.identifier.urihttp://hdl.handle.net/20.500.14038/32260
dc.description.abstractDisruptions in cardiac development cause congenital heart disease, the most prevalent and deadly congenital malformation. Genetic and environmental factors are thought to contribute to these defects, however molecular mechanisms remain largely undefined. Recent work highlighted potential roles of chromatin- modifying enzymes in congenital heart disease pathogenesis. Histone deacetylases, a class of chromatin-modifying enzymes, have developmental importance and recognized roles in the mature heart. This thesis aimed to characterize functions of Hdac3 in cardiac development. We found loss of Hdac3 in the primary heart field causes precocious progenitor cell differentiation, resulting in hypoplastic ventricular walls, ventricular septal defect, and mid- gestational lethality. In primary heart field progenitors, Hdac3 interacts with, deacetylates, and functionally suppresses transcription factor Tbx5. Furthermore, a disease-associated Tbx5 mutation disrupts this interaction, rendering Tbx5 hyperacetylated and hyperactive. By contrast, deletion of Hdac3 in second heart field progenitors bypasses these defects, instead causing malformations in the outflow tract and semilunar valves, with lethality prior to birth. Affected semilunar valves and outflow tract vessels exhibit extracellular matrix and EndMT defects and activation of the Tgfβ1 signaling pathway. In normal second heart field development, Hdac3 represses Tgfβ1 transcription, independent of its deacetylase activity, by recruiting the PRC2 methyltransferase complex to methylate the Tgfβ1 promoter. Importantly, knockouts of Hdac3 in differentiated cardiac cells do not fully recapitulate the progenitor-specific knockout phenotypes. These results illustrate spatiotemporal roles of Hdac3, both deacetylase-dependent and deacetylase-independent, in cardiac development, suggesting that dysregulation of Hdac3 in cardiac progenitor cells could be a contributing factor in congenital heart disease pathogenesis.
dc.language.isoen_US
dc.publisherUniversity of Massachusetts Medical School
dc.rightsLicensed under a Creative Commons license
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectHdac3
dc.subjecthistone deacetylase
dc.subjectcardiac development
dc.subjectheart
dc.subjectcongenital heart disease
dc.subjectprimary heart field
dc.subjectsecond heart field
dc.subjectprogenitor cells
dc.subjectdevelopment
dc.subjectchromatin
dc.subjectepigenetics
dc.subjectgene regulation
dc.subjectTbx5
dc.subjectTgf-beta
dc.subjectCell and Developmental Biology
dc.subjectCell Biology
dc.subjectCongenital, Hereditary, and Neonatal Diseases and Abnormalities
dc.subjectDevelopmental Biology
dc.subjectMolecular Genetics
dc.titleHistone Deacetylase 3 Coordinates Heart Development Through Stage-Specific Roles in Cardiac Progenitor Cells
dc.typeDoctoral Dissertation
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1885&context=gsbs_diss&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_diss/883
dc.legacy.embargo2017-01-30T00:00:00-08:00
dc.identifier.contextkey9597238
refterms.dateFOA2022-08-25T04:18:30Z
html.description.abstract<p>Disruptions in cardiac development cause congenital heart disease, the most prevalent and deadly congenital malformation. Genetic and environmental factors are thought to contribute to these defects, however molecular mechanisms remain largely undefined. Recent work highlighted potential roles of chromatin- modifying enzymes in congenital heart disease pathogenesis. Histone deacetylases, a class of chromatin-modifying enzymes, have developmental importance and recognized roles in the mature heart. This thesis aimed to characterize functions of Hdac3 in cardiac development. We found loss of Hdac3 in the primary heart field causes precocious progenitor cell differentiation, resulting in hypoplastic ventricular walls, ventricular septal defect, and mid- gestational lethality. In primary heart field progenitors, Hdac3 interacts with, deacetylates, and functionally suppresses transcription factor Tbx5. Furthermore, a disease-associated Tbx5 mutation disrupts this interaction, rendering Tbx5 hyperacetylated and hyperactive. By contrast, deletion of Hdac3 in second heart field progenitors bypasses these defects, instead causing malformations in the outflow tract and semilunar valves, with lethality prior to birth. Affected semilunar valves and outflow tract vessels exhibit extracellular matrix and EndMT defects and activation of the Tgfβ1 signaling pathway. In normal second heart field development, Hdac3 represses Tgfβ1 transcription, independent of its deacetylase activity, by recruiting the PRC2 methyltransferase complex to methylate the Tgfβ1 promoter. Importantly, knockouts of Hdac3 in differentiated cardiac cells do not fully recapitulate the progenitor-specific knockout phenotypes. These results illustrate spatiotemporal roles of Hdac3, both deacetylase-dependent and deacetylase-independent, in cardiac development, suggesting that dysregulation of Hdac3 in cardiac progenitor cells could be a contributing factor in congenital heart disease pathogenesis.</p>
dc.identifier.submissionpathgsbs_diss/883
dc.contributor.departmentCardiovascular Medicine
dc.description.thesisprogramTranslational Science
dc.identifier.orcid0000-0002-5830-9962


Files in this item

Thumbnail
Name:
Lewandowski_Sara_preflight_ver ...
Size:
1.748Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Licensed under a Creative Commons license
Except where otherwise noted, this item's license is described as Licensed under a Creative Commons license